Results from a three-year trial suggest an experimental gene therapy for Huntington's disease can slow the progression of the deadly condition by 75%.

Earth’s most diverse biological entities are the viruses that infect bacteria, called bacteriophages (phages). They are rich resources for discovering proteins and tools for biotechnology, but many ...

In celebration of University Research Week (October 20-24), the UNC School of Medicine is proud to announce the winners of ...

Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy for Parkinson’s disease.

Stimulation of the A13 brain region restores motor function in Parkinson's disease mouse models by alleviating bradykinesia and akinesia.

Every time a eukaryotic cell divides, it faces a monumental challenge: It must carefully duplicate and divide its genetic material (chromosomes ...

A novel YAP/TEAD regulatory mechanism by NSP13 provides molecular insights into Hippo-YAP regulation after SARS-CoV-2 infection.

Every time a eukaryotic cell divides, it faces a monumental challenge: It must carefully duplicate and divide its genetic ...

UCLA researchers have made strides in developing a stem cell gene therapy for alpha thalassemia major, a severe, inherited ...

Research on rare post-mortem brain tissue shows changes in gene activity, offering new insight into the biological basis of depression. Researchers from McGill University and the Douglas Institute hav ...

Lab-grown brain cells improved stroke recovery in mice by repairing circuits and reducing damage. Human trials could follow within 5–7 years.